These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1388680)

  • 1. Determination of basal dose rates in Paris system of interstitial implants.
    Saw CB; Wu A
    Med Dosim; 1992; 17(3):145-50. PubMed ID: 1388680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
    Ho Than MT; Munro Iii JJ; Medich DC
    J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The guide gutter or loop techniques of interstitial implantation and the Paris system of dosimetry.
    Marinello G; Wilson JF; Pierquin B; Barret C; Mazeron JJ
    Radiother Oncol; 1985 Nov; 4(3):265-73. PubMed ID: 3841221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between continuous and discrete sources in the Paris system of implants.
    Paul JM; Philip PC; Brandenburg RW; Koch RF
    Med Phys; 1989; 16(3):414-24. PubMed ID: 2739623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the substitution of Ir-192 seed ribbons for wires in Paris system using dose nonuniformity ratio.
    Saw CB; Wu A
    Int J Radiat Oncol Biol Phys; 1993 Feb; 25(3):551-6. PubMed ID: 8436534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources.
    Krishnamurthy D; Weinberg V; Cunha JA; Hsu IC; Pouliot J
    Brachytherapy; 2011; 10(6):461-5. PubMed ID: 21397569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scattering effects on the dosimetry of iridium-192.
    Serago CF; Houdek PV; Pisciotta V; Schwade JG; Abitbol AA; Lewin AA; Poole DO; Marcial-Vega V
    Med Phys; 1991; 18(6):1266-70. PubMed ID: 1753916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reference dose rates for single- and double-plane 192Ir implants.
    Saw CB; Suntharalingam N
    Med Phys; 1988; 15(3):391-6. PubMed ID: 3405143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformality and homogeneity of dose distributions in interstitial implants at idealized target volumes: a comparison between the Paris and dose-point optimized systems.
    Major T; Polgár C; Fodor J; Somogyi A; Németh G
    Radiother Oncol; 2002 Jan; 62(1):103-11. PubMed ID: 11830318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comments on the calibration of pre-cut iridium-192 wires for low dose rate interstitial brachytherapy using a farmer-type ionization chamber.
    Plane JH
    Br J Radiol; 2001 Mar; 74(879):291-3. PubMed ID: 11338112
    [No Abstract]   [Full Text] [Related]  

  • 11. Anisotropy functions for 103Pd, 125I, and 192Ir interstitial brachytherapy sources.
    Nath R; Meigooni AS; Muench P; Melillo A
    Med Phys; 1993; 20(5):1465-73. PubMed ID: 8289730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dosimetric comparison of 169Yb and 192Ir for HDR brachytherapy of the breast, accounting for the effect of finite patient dimensions and tissue inhomogeneities.
    Lymperopoulou G; Papagiannis P; Angelopoulos A; Karaiskos P; Georgiou E; Baltas D
    Med Phys; 2006 Dec; 33(12):4583-9. PubMed ID: 17278810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single and double plane implants: a comparison of the Manchester System with the Paris System.
    Gillin MT; Kline RW; Wilson JF; Cox JD
    Int J Radiat Oncol Biol Phys; 1984 Jun; 10(6):921-5. PubMed ID: 6735776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetry of intraluminal brachytherapy.
    Marinello G; Pierquin B; Grimard L; Barret C
    Radiother Oncol; 1992 Apr; 23(4):213-6. PubMed ID: 1609124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does inverse planning applied to Iridium192 high dose rate prostate brachytherapy improve the optimization of the dose afforded by the Paris system?
    Nickers P; Lenaerts E; Thissen B; Deneufbourg JM
    Radiother Oncol; 2005 Feb; 74(2):131-6. PubMed ID: 15734200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consequences of optimization in PDR brachytherapy--is a routine geometrical optimization recommendable?
    Berns C; Fritz P; Hensley FW; Wannenmacher M
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1171-80. PubMed ID: 9169828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of dose-volume histograms to the Paris and Manchester systems of brachytherapy dosimetry.
    Langmack KA; Thomas SJ
    Br J Radiol; 1995 Jan; 68(805):42-8. PubMed ID: 7881882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of planar high-dose-rate implants.
    Zwicker RD; Arthur DW; Kavanagh BD; Mohan R; Schmidt-Ullrich RK
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1171-7. PubMed ID: 10421552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distortions induced by radioactive seeds into interstitial brachytherapy dose distributions.
    Zhou C; Inanc F; Modrick JM
    Med Phys; 2004 Dec; 31(12):3393-405. PubMed ID: 15651622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose volume assessment of high dose rate 192Ir endobronchial implants.
    Saw CB; Korb LJ; Pawlicki T; Wu A
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):917-22. PubMed ID: 8598371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.